Evidence-informed actives & dosages; excipient strategy; allergen constraints.
Formats: capsules, powders (others case-by-case)
Flavor systems & sweeteners (for powders)
Label design & printing aligned to the final formula and claims
Compliance review for panel & copy (FDA/FTC-aligned)
MOQ: typically ≥ 2000; may be higher for certain formats/flavors.
Timing: add ~1–3 weeks for R&D/pilot on top of production timeline.
Docs: Spec Sheet + QA Release + QC Summary; COA under NDA (redacted/view-only) or third-party retest.
Quality statement: Manufactured in US GMP-certified, FDA-registered & inspected facilities. Standard documentation includes Batch QC Summary, QA Release Letter, and Finished Product Specifications. COA access under NDA (redacted) or third-party retest available upon request.
Copyright © 2025 Quanture Nutraceuticals - All Rights Reserved.
Usamos cookies para analizar el tráfico del sitio web y optimizar tu experiencia en el sitio. Al aceptar nuestro uso de cookies, tus datos se agruparán con los datos de todos los demás usuarios.